BioMed Research International / 2015 / Article / Tab 3

Clinical Study

Comparison of Propofol, Propofol-Remifentanil, and Propofol-Fentanyl Administrations with Each Other Used for the Sedation of Patients to Undergo ERCP

Table 3

Distribution of groups in terms of other clinical results.

Follow-up timeGroup IGroup IIGroup III value

Total dose of propofol (mg)375 (100–950)150 (80–350)245 (100–550)<0.05
Aldrete score9 (9-10)9 (9-10)9 (9-10)0.104
Pain 0.002
 No pain13 (%43.3)25 (%83.3)16 (%53.3)
 Mild 8 (%26.7)5 (%16.7)9 (%30.0)
 Severe 6 (%20.0)0 (%0)5 (%16.7)
 Extremely severe3 (%10.0)0 (%0)0 (%0)
Quality of surgery
 Well8 (%26.7)3 (%10.0)6 (%20.0)
 Very well 22 (%73.3)27 (%90.0)24 (%80.0)

a = difference between Group I and Group II was statistically significant (), b = difference between Group I and Group III was statistically significant (), c = difference between Group II and Group III was statistically significant ().